Non-compliance on the part of the professional community with a national guideline: an argumentative policy analysis.
until further notice
SourceHealth Policy, 78, 2-3, (2006), pp. 353-359
Article / Letter to editor
Display more detailsDisplay less details
Medical Technology Assessment
SubjectCTR 2: Clinical Pharmacology and physiology; DCN 2: Functional Neurogenomics; EBP 2: Effective Hospital Care; N4i 1: Pathogenesis and modulation of inflammation; NCEBP 2: Evaluation of complex medical interventions; UMCN 3.2: Cognitive neurosciences; CTR 2: Clinical Pharmacology and physiology
In 1997, the National Health Insurance Board of the Netherlands (CVZ) introduced a guideline for the use of a new anti-epileptic drug, Lamotrigine. The goal was to limit the use of this relatively expensive drug to patients with difficult-to-treat epilepsy. A survey had shown that only a minority of neurologists were familiar with the guideline, and even fewer applied it in practice. In the present study, interviews were held with stakeholders to obtain a better understanding of why this policy measure failed. The results indicate that the problem definitions of policy maker and practicing neurologists differed widely, and that the policy measure was conflicting with certain professional beliefs. In such cases, the theory of argumentative policy predicts that policy is unlikely to succeed, unless policy makers take actions to ensure a greater congruence in interpretative frames between them and their target population.
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.